Copy number alteration burden predicts prostate cancer relapse: Agilent 1M aCGH data for human primary prostate cancer samples

Authors

Hieronymus, Haley

Schultz, Nikolaus D.

Taylor, Barry Stephen

Sawyers, Charles L.

Description

Summary from GEO: "Prostate cancer is the most common malignancy in men. Yet, the modest benefit of treatment highlights the unmet need for prognostic biomarkers in prostate cancer (1). Few large prostate oncogenome resources currently exist that combine the molecular and clinical outcome data necessary for prognostic discovery. To determine the extent to which genomic aberrations reflect the risk...

Subject

Biomarkers, Tumor

Genomics

Neoplasm Metastasis

Prostatic Neoplasms

Recurrence

Access Rights

Free to All